Evidence map›Paper›PMID 26940143›Full record

ArticleClinical and experimental immunology2016

MICA*A4 protects against ulcerative colitis, whereas MICA*A5.1 is associated with abscess formation and age of onset.

A Martinez-Chamorro, A Moreno, M Gómez-García, M J Cabello, J Martin, M Á Lopez-Nevot

Open access · greenAbstract read
In one paragraph

Article in Clinical and experimental immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Leveraging NKG2D Ligands in Immuno-Oncology.Frontiers in immunology · 2021
    Review
  2. Review
  3. Anti-NKG2D mAb: A New Treatment for Crohn's Disease?International journal of molecular sciences · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

A Martinez-ChamorroSection of Immunology, Hospital Virgen de las Nieves.
A MorenoSection of Immunology, Hospital Virgen de las Nieves.
M Gómez-GarcíaDigestive Section, Hospital Virgen de las Nieves.
M J CabelloDigestive Section, Hospital Virgen de las Nieves.
J MartinInstitute of Parasitology and Biomedicine López-Neyra, CSIC, Granada, Spain.
M Á Lopez-NevotSection of Immunology, Hospital Virgen de las Nieves.
Hospital Universitario Virgen de las Nieves · ESInstituto de Parasitología y Biomedicina "López - Neyra" · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ulcerative colitis (UC) is one of the two major forms of inflammatory bowel disease, the aetiology of which remains unknown. Several studies have demonstrated the genetic basis of disease, identifying more than 130 susceptibility loci. The major histocompatibility complex class I chain-related gene A (MICA) is a useful candidate to be involved in UC pathogenesis, because it could be important in recognizing the integrity of the epithelial cell and its response to stress. The aim of this study was to analyse the relationship between polymorphisms in the transmembrane domain of MICA and susceptibility to develop UC. A total of 340 patients with UC and 636 healthy controls were genotyped for MICA transmembrane polymorphism using a polymerase chain reaction (PCR) combined with fluorescent technology. Different MICA alleles were determined depending on the PCR product size. The allele MICA*A4 was less frequent in patients than in controls (P = 0·003; OR = 0·643), and this protective role is higher when it forms haplotype with B*27 (P = 0·002; OR = 0·294). The haplotype HLA-B*52/MICA*A6 was also associated with UC [P = 0·001; odds ratio (OR) = 2·914]. No other alleles, genotypes or haplotypes were related with UC risk. Moreover, MICA*A5.1 is associated independently with abscesses (P = 0·002; OR = 3·096) and its frequency is lower in patients diagnosed between ages 17 and 40 years (P = 0·007; OR = 0·633), meaning an extreme age on onset. No association with location, extra-intestinal manifestations or need for surgery was found.

Indexed as

Genetic Predisposition to DiseaseAbscessAdultAge of OnsetAllelesAmino Acid SequenceCase-Control StudiesColitis, UlcerativeFemaleGene ExpressionGene FrequencyHaplotypesHistocompatibility Antigens Class IHLA-B27 AntigenHLA-B52 AntigenHumansHistocompatibility Antigens Class IHLA-B27 AntigenHLA-B52 AntigenMHC class I-related chain AProtein Isoformsautoimmunitycell surface moleculesinflammationMHCmolecular biology

Identifiers

PMID26940143
PMCPMC4872378
OpenAlexW2290754495

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.